First-in-class gene therapy to reverse neurodegeneration at its epigenetic root
YouthBio is developing precision gene therapies that use partial cellular reprogramming to treat Alzheimer's and other brain diseases. One injection. Activated by pill. Built on Nobel Prize–winning science.
~7.2M
AD PATIENTS IN THE US
~50M
AD PATIENTS WORLDWIDE
~$30B/yr
ALZHEIMER'S DRUG MARKET
0
THERAPIES THAT CAN REVERSE AD
MEET THE CEO
Yuri Deigin on why partial reprogramming can change everything
Hear from our co-founder and CEO on why tissue-specific cellular reprogramming represents a paradigm shift in treating Alzheimer's — and why YouthBio is uniquely positioned to bring this science to the clinic.
Yuri Deigin on why partial reprogramming can change everything
Hear from our co-founder and CEO on why tissue-specific cellular reprogramming represents a paradigm shift in treating Alzheimer's — and why YouthBio is uniquely positioned to bring this science to the clinic.
© All rights reserved. YouthBio Therapeutics Inc.